It is more likely that, as knowledge of the role of immunosuppressive therapies in SSc develops, data will also show a positive trend towards a reduction in the use of GCs in Latvia.
← all excerpts
Prevalence and gender - specific analysis of a systemic sclerosis cohort in Latvia.
1
—
—